Geode Capital Management, LLC Palisade Bio, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.41 - $1.04 $1,263 - $3,204	3,081 Added 2.43%	130,017 $53,000
Q1 2022 May 13, 2022	SELL	$0.81 - $1.51 $66,117 - $123,256	-81,627 Reduced 39.14%	126,936 $134,000
Q4 2021 Feb 11, 2022	BUY	$1.3 - $2.96 $48,142 - $109,617	37,033 Added 21.59%	208,563 $271,000
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.93 $345,109 - $577,140	146,855 Added 595.16%	171,530 $454,000
Q2 2021 Aug 13, 2021	BUY	$3.49 - $11.34 $86,115 - $279,814	24,675 New	24,675 $100,000

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $320M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.